Korea Leveraged ETF Trading Hits 20% of Assets vs US 5%

Korea Investment & Securities released a report on the 14th analyzing single-stock leveraged ETF trading volumes amid recent KOSPI volatility concerns. The report, titled 'Understanding Leveraged ETFs: Examining the Impact on Volatility Expansion,' found that Korea's single-stock leveraged ETF trading volumes represent over 20% of underlying asset values, compared to 5% in the US market. Single-stock leveraged ETFs have been identified as a contributing factor to the recent expansion of volatility in the KOSPI. The analysis highlights a significant structural difference in leveraged ETF market participation between the two markets.

Korea Investment & Securities Report Reveals 20% Trading Volume Ratio

The report by Korea Investment & Securities documented that single-stock leveraged ETF trading volumes in Korea account for over 20% of the underlying asset's trading value. In contrast, the same metric in the US market stands at approximately 5%. The analysis attributed this disparity partly to the early-stage nature of Korea's single-stock leveraged ETF market. The report was authored by Kim Tae-jong and published through Yonhap News.

FAQ

What percentage of underlying assets do Korea's single-stock leveraged ETFs represent in trading volume? Korea's single-stock leveraged ETF trading volumes represent over 20% of the underlying asset's trading value, according to the Korea Investment & Securities report released on the 14th.

How does Korea's leveraged ETF trading volume compare to the US market? Korea's single-stock leveraged ETF trading volumes account for over 20% of underlying assets, while the US market's equivalent figure is approximately 5%, as documented in the Korea Investment & Securities analysis.

Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments